Espero Biopharma (formerly known as Espero Pharmaceuticals) is a biopharmaceutical company focused on the development of drugs for cardiovascular treatments. It offers tecarfarin for patients requiring chronic anticoagulation and an anti-arrhythmic drug (AAD) program to treat atrial fibrillation (AFib).